Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2008
08/13/2008EP1954691A2 Amorphous and crystalline forms of pantoprazole magnesium salt
08/13/2008EP1954690A1 Benzamide compounds useful as histone deacetylase inhibitors
08/13/2008EP1954689A1 N-substituted-1h-quinoline-2, 4-diones, preparation method thereof, and pharmaceutical composition containing the same
08/13/2008EP1954688A1 Novel thiophene derivatives
08/13/2008EP1954685A2 Furoxan compounds, compositions and methods of use
08/13/2008EP1954684A2 Oxazole compound and pharmaceutical composition
08/13/2008EP1954683A1 2-(phenyl or heterocyclic)-1h-phenantrho(9,10-d)imidazoles as mpges-1 inhibitors
08/13/2008EP1954682A1 Novel 2-amino-imidazole-4-one compounds and their use in the manufacture of a medicament to be used in the treatment of cognitive impairment, alzheimer s disease, neurodegeneration and dementia
08/13/2008EP1954681A2 Compounds and methods for thiol-containing compound efflux and cancer treatment
08/13/2008EP1954678A1 Novel nk1 and nk2 antagonists
08/13/2008EP1954677A1 Thiomorpholine compound and process for preparing the same
08/13/2008EP1954673A1 Hydroxy-substituted diphenylazetidinones for the treatment of hyperlipidaemia
08/13/2008EP1954670A2 Nuclear receptor binding agents
08/13/2008EP1954669A1 Substituted phenethylamines with serotoninergic and/or norepinephrinergic activity
08/13/2008EP1954652A2 An improved process for the preparation of armodafinil
08/13/2008EP1954322A2 Mitochondria-targeted antioxidant prodrugs and methods of use
08/13/2008EP1954320A2 Compositions comprising lipoxygenase inhibitors and cyclodextrin
08/13/2008EP1954316A1 Methods of treating anxiety disorders
08/13/2008EP1954315A2 Use of oligouronates for treating mucus hyperviscosity
08/13/2008EP1954314A2 Preparation, comprising iron(iii) complex compounds and redox-active substances
08/13/2008EP1954304A2 Compositions and methods for prolonging survival of platelets
08/13/2008EP1954303A2 Improved reproductive management
08/13/2008EP1954301A1 Confectionary compositions with magnolia bark extract
08/13/2008EP1954295A1 Composition having effect on treatment and prevention of dry eye syndrome
08/13/2008EP1954294A2 Use of macrolide derivatives for treating acne
08/13/2008EP1954293A1 Oleuropein for the treatment of conditions associated to the peripheral vascular disease
08/13/2008EP1954292A2 Compositions useful for reducing nephrotoxicity and methods of use thereof
08/13/2008EP1954291A1 Treatment and prevention of bone loss using resolvins
08/13/2008EP1954289A2 Use of guanabenz and its derivatives for making drugs for treating cystic fibrosis and diseases related to a protein addressing deficiency in the cells
08/13/2008EP1954288A1 Amidine derivatives and their uses as medicine
08/13/2008EP1954287A2 Cetp inhibitors
08/13/2008EP1954286A2 Inhibitors of akt activity
08/13/2008EP1954285A2 Transglutaminase inhibitors and methods of use thereof
08/13/2008EP1954284A1 Method of treating cancers with saha and pemetrexed
08/13/2008EP1954283A2 Compounds for modulating trpv3 function
08/13/2008EP1954282A2 Novel process and formulations
08/13/2008EP1954281A2 Cancer treatment method
08/13/2008EP1954280A2 Compositions comprising a combination of ccr5 and cxcr4 antagonists
08/13/2008EP1954279A1 Composition for preventing or treating damages of the mucosa in the gastrointestinal tracts
08/13/2008EP1954278A2 Combination comprising a pyrimidylaminobenzamides and a flt-3 inhibitor for treating proliferative diseases
08/13/2008EP1954277A2 Aminopyrimidines useful as kinase inhibitors
08/13/2008EP1954276A2 Indole orexin receptor antagonists
08/13/2008EP1954275A2 Pharmaceutical compositions comprising buprenorphine
08/13/2008EP1954274A2 Substituted quinolones and methods of use
08/13/2008EP1954273A1 Treatment of stress urinary incontinence and mixed urinary incontinence
08/13/2008EP1954272A2 Treatment of cancer with sorafenib
08/13/2008EP1954270A1 Rapamycin derivative or an impdh inhibitor for treating polycystic kidney disease
08/13/2008EP1954269A2 Neuroendocrine tumor treatment using mtor inhibitors
08/13/2008EP1954268A2 Spirolactam bicyclic cgrp receptor antagonists
08/13/2008EP1954267A1 Organic compounds comprising a glycopyrronium salt
08/13/2008EP1954266A1 Organic compounds comprising a glycopyrrolium salt
08/13/2008EP1954265A2 Compositions containing ansamycin
08/13/2008EP1954264A2 Process for the manufacture of epoxybutanol intermediates
08/13/2008EP1954263A2 Composition for increasing steady state plasma levels of bicalutamide
08/13/2008EP1954262A2 Compositions for regulating metabolic disorders and methods of use thereof
08/13/2008EP1954261A2 Use of fenofibrate or a derivative thereof for preventing diabetic retinopathy
08/13/2008EP1954260A2 Isocystene derivatives for the treatment of pain
08/13/2008EP1954259A2 Amidine derivatives for in vivo imaging
08/13/2008EP1954258A1 Materials and methods for treating viral infections with a cysteamine compound
08/13/2008EP1954257A2 Methods of treating central nervous system disorders with a low dose combination of escitalopram and bupropion
08/13/2008EP1954256A2 Pharmaceutical composition comprising a compound having a catechol moiety and an alkalising agent
08/13/2008EP1954255A1 A combination comprising squalene, a phospholipid and an omega 3 fatty acid for the treatment of cancer
08/13/2008EP1954254A2 Modulating endoplasmic reticulum stress in the treatment of tuberous sclerosis
08/13/2008EP1954253A1 Nanoparticulate and controlled release compositions comprising cefditoren
08/13/2008EP1954247A1 Pharmaceutical compositions
08/13/2008EP1954245A2 Compositions of lipoxygenase inhibitors
08/13/2008EP1954241A1 Sustained-release formulation of zonisamide
08/13/2008EP1954240A2 Drospirenone containing transdermal drug delivery devices and methods of delivery thereof
08/13/2008EP1954142A1 Pediculicide/ovicide composition
08/13/2008EP1954139A2 Glyceryl ether compounds and their use
08/13/2008EP1954137A2 2-keto-oxazoles as modulators of fatty acid amide hydrolase
08/13/2008EP1954136A2 Novel chemical compounds
08/13/2008EP1954135A2 Spirolactam aryl cgrp receptor antagonists
08/13/2008EP1954134A2 Process for synthesizing 2-phenyl-1h-phenantrho[9,10-d]imidazole derivative
08/13/2008EP1954133A2 Pyrrolidineanilines
08/13/2008EP1954132A2 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
08/13/2008EP1954128A2 Diphenylmethane derivatives as inhibitors of leukotriene biosynthesis
08/13/2008EP1898692A4 Alternate morpheeins of allosteric proteins as a target for the development of bioactive molecules
08/13/2008EP1869032B1 Pyrimidine derivatives for use as anticancer agents
08/13/2008EP1866280B1 Acyl hydrazides as kinase inhibitors, in particular for sgk
08/13/2008EP1828177B1 Novel mch receptor antagonists
08/13/2008EP1824837B1 Substituted n-sulfonylaminobenzyl-2-phenoxy acetamide compounds
08/13/2008EP1811981B1 Process for the preparation of suspension aerosol formulations, wherein the particles are formed by precipitation inside an aerosol canister
08/13/2008EP1781649B1 Substituted hydantoins
08/13/2008EP1768657B1 Methods and compositions for treating ophthalmic conditions with retinyl derivates
08/13/2008EP1758870B1 4-phenyl-pyrimidine-2-carbonitrile derivatives
08/13/2008EP1753763B1 Indazole and indolone derivatives and their use as pharmaceuticals
08/13/2008EP1753723B1 Substituted quinoline derivatives as mitotic kinesin inhibitors
08/13/2008EP1746981B1 Medicinal aerosol formulation products with improved chemical stability
08/13/2008EP1740164B1 Statins for the treatment of ocular hypertension and glaucoma
08/13/2008EP1704136B1 Gossypol derivatives, production method thereof and uses of same
08/13/2008EP1686978B1 Use of idrocilamide for the preparation of a pharmaceutical composition for the treatmentof rosacea
08/13/2008EP1664023B1 Sustituted isoquinoline derivatives and methods of use
08/13/2008EP1660054B1 Agent containing ergolin for transdermal application
08/13/2008EP1635850B1 Antimicrobial silver comprising silver
08/13/2008EP1603894B1 Pharmacologically active novel dauer pheromone compound for controlling aging and stress and method for isolating and characterizing the same
08/13/2008EP1603532B1 Subcutaneous delivery system, process for the preparation of the same and use of the same for the treatment of cholinergic deficient disorders
08/13/2008EP1590337B1 Acylaminothiazole derivatives, preparation method thereof and use of same as beta-amyloid peptide production inhibitors
08/13/2008EP1589949B1 Stabilized lyophilized compositions comprising tissue factor pathway inhibitor or tissue factor pathway inhibitor variants
08/13/2008EP1585749B1 Diazepinoindole derivatives as kinase inhibitors
1 ... 3136 3137 3138 3139 3140 3141 3142 3143 3144 3145 3146 3147 3148 3149 3150 3151 3152 3153 3154 3155 3156 ... 7860